Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 40,04 € (+7,35 %). Medianen er 40,49 € (+8,55 %).
| Køb |
6 |
| Behold |
1 |
| Sælg |
0 |
Nyheder Til nyhedsfeedet
Pennant Group beats Q2 estimates and raises full-year outlook
For Q2 2026 Pennant Group reported adjusted earnings of $0.36 per share and revenue of $298.0 million, both above consensus estimates, with revenue up 35.8% and adjusted EBITDA up 48.2%. Management raised its full-year guidance, citing faster integration of acquisitions and organic growth in home care, hospice services and senior living. The stock was little changed, while analysts see valuation risks and investors should monitor the sustainability of growth as integration continues. » Mere på de.investing.com
Pennant Group reaches 52-week high at $42.58
Pennant Group shares climbed to a new yearly high of $42.58, giving the company a market capitalization of $1.48 billion. The stock rose 84.73% year‑over‑year, supported by revenue growth of 36.76% over the last twelve months. Analysts raised earnings estimates, but the P/E ratio stands at 49.12, suggesting possible overvaluation. Pennant reported strong Q1 results (EPS $0.32; revenue $285.36 million) and acquired Copper Canyon Memory Care (40 units) to expand in Arizona, bringing its presence to 17 states. » Mere på de.investing.com
Pennant Group reaches 52-week high at $42.55
Pennant Group's stock climbed to a 52-week high of $42.55 and is up about 80.64% year over year. The company has a market capitalization of $1.46 billion, with revenue growth of 37% over the past twelve months; the P/E ratio is 48.33 according to InvestingPro. In Q1 2026 Pennant beat expectations with EPS of $0.32 and revenue of $285.36 million and announced the acquisition of Copper Canyon Memory Care (40 units) in Tucson. » Mere på de.investing.com
Virksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 261,1 mio. | 40,20 % |
| Bruttofortjeneste | 36,73 mio. | 42,88 % |
| Nettoresultat | 7,96 mio. | 32,38 % |
| EBITDA | 16,91 mio. | 42,32 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 1,32 mia. € |
Antal aktier | 34,93 mio. |
Højeste/laveste i 52 uger | 38,46 € - 20,03 € |
| Udbytte | Nej |
Beta | 1,25 |
P/E (PE Ratio) | 44,55 |
PEG (PEG Ratio) | 2,78 |
K/I (PB Ratio) | 4,06 |
P/S (PS Ratio) | 1,33 |
Virksomhedsprofil
The Pennant Group, Inc. leverer sundhedsydelser i USA. Virksomheden opererer i to segmenter, Home Health and Hospice Services samt Senior Living Services. Selskabet tilbyder hjemmesygeplejeydelser, herunder kliniske ydelser såsom sygepleje, talterapi, ergoterapi og fysioterapi, medicinsk socialt arbejde og hjælp fra hjemmeplejere; og hospiceydelser, der omfatter klinisk pleje, undervisning og rådgivning til dækning af de fysiske, åndelige og psykosociale behov hos uhelbredeligt syge patienter og deres familier. Det leverer også seniorboligydelser, såsom beboelse, aktiviteter, måltider, rengøring og hjælp til dagligdagens gøremål for seniorer, som er selvhjulpne, eller som har brug for en vis støtte. Pr. 31. december 2021 drev selskabet 88 hjemmesygeplejerske- og hospiceagenturer samt 54 seniorboligcentre med 4127 seniorboligenheder i Arizona, Californien, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin og Wyoming. The Pennant Group, Inc. blev stiftet i 2019 og har hovedkvarter i Eagle, Idaho.
| Navn | PENNANT GROUP DL -,001 |
| CEO | Brent J. Guerisoli |
| Hjemsted | Eagle,
id USA |
| Websted | |
| Sektor | Sundhed |
| Branche | Sundhedsudbydere og -tjenester |
| Børsnotering | 01.10.2019 |
| Medarbejdere | 9.700 |
Tickersymboler
| Børs | Symbol |
|---|---|
NASDAQ | PNTG |
Frankfurt | 1ZU.F |
Düsseldorf | 1ZU.DU |
München | 1ZU.MU |